These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 239322)

  • 61. [Multiple therapeutic advances].
    Massol J
    Presse Med; 1998 Dec; 27(39):2013. PubMed ID: 9917245
    [No Abstract]   [Full Text] [Related]  

  • 62. The topical steroid saga.
    Parish LC; Witkowski JA
    Int J Dermatol; 1978 Apr; 17(3):218-9. PubMed ID: 418011
    [No Abstract]   [Full Text] [Related]  

  • 63. FDA, advisers mull "polypill" for patients with cardiovascular disease.
    Traynor K
    Am J Health Syst Pharm; 2014 Nov; 71(22):1918, 1920. PubMed ID: 25349232
    [No Abstract]   [Full Text] [Related]  

  • 64. Essential drugs committee views on drugs.
    Indian J Pediatr; 1974 May; 41(316):198-9. PubMed ID: 4443026
    [No Abstract]   [Full Text] [Related]  

  • 65. Drugs recently released in Belgium.
    Harvengt C
    Acta Clin Belg; 1984; 39(6):396-8. PubMed ID: 6099949
    [No Abstract]   [Full Text] [Related]  

  • 66. Significance.
    Gribble GW
    Fortschr Chem Org Naturst; 2010; 91():375-6. PubMed ID: 19953389
    [No Abstract]   [Full Text] [Related]  

  • 67. New drug introduction 1973-1974.
    de Haen P
    JAMA; 1975 Nov; 234(7):728-33. PubMed ID: 1242454
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The stagnation of therapeutic progress.
    Howard JC
    Psychosomatics; 1973; 14(1):12-8. PubMed ID: 4795126
    [No Abstract]   [Full Text] [Related]  

  • 69. Anti-inflammatory therapy in the treatment of cardiovascular diseases.
    Tomaniak M; Filipiak KJ
    Kardiol Pol; 2015; 73(12):1295-303. PubMed ID: 26412468
    [No Abstract]   [Full Text] [Related]  

  • 70. Control of drug usage.
    Goulston S
    Med J Aust; 1981 Feb; 1(4):166-8. PubMed ID: 7015090
    [No Abstract]   [Full Text] [Related]  

  • 71. Therapeutic potential of peptide motifs - part III.
    Hervé JC
    Curr Pharm Des; 2010; 16(9):1021-3. PubMed ID: 20236078
    [No Abstract]   [Full Text] [Related]  

  • 72. [COOPERATION OF PRACTICING PHYSICIANS IN THE TESTING OF NEW DRUGS,SUCH AS, MEXAFORM].
    IMHOF P; STAMM W
    Praxis; 1964 Nov; 53():1595-8. PubMed ID: 14317120
    [No Abstract]   [Full Text] [Related]  

  • 73. [Current therapy 2001].
    Scheen AJ
    Rev Med Liege; 2001 Sep; 56(9):612-24. PubMed ID: 11702503
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development of medicinals and the dilemma of patient care.
    Hubbard WN
    Perspect Biol Med; 1982; 25(4):688-97. PubMed ID: 7167366
    [No Abstract]   [Full Text] [Related]  

  • 75. AIMECS 07 - Sixth AFMC International Medicinal Chemistry Symposium.
    Shah S
    IDrugs; 2007 Sep; 10(9):610-3. PubMed ID: 17786840
    [No Abstract]   [Full Text] [Related]  

  • 76. Anti-inflammatory drugs and the heart.
    Roubille F; Tardif JC
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(1):2. PubMed ID: 23330990
    [No Abstract]   [Full Text] [Related]  

  • 77. The latest advances in the use of conventional anti-inflammatory drugs and agents. Preface.
    Tunctan B
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(1):1. PubMed ID: 23330991
    [No Abstract]   [Full Text] [Related]  

  • 78. Letter: Topical steroid addicts.
    Kligman AM
    JAMA; 1976 Apr; 235(15):1550. PubMed ID: 946265
    [No Abstract]   [Full Text] [Related]  

  • 79. New potential chemotherapeutic agents; derivatives of benziminazole.
    KING FE; BEER RJ; WALEY SG
    J Chem Soc; 1946 Feb; ():92-4. PubMed ID: 21022270
    [No Abstract]   [Full Text] [Related]  

  • 80. Abstracts of papers presented at the session of the German Pharmaceutical Society. March 7-9, 1990, Regensburg.
    Arch Pharm (Weinheim); 1990 Aug; 323(8):525-59. PubMed ID: 2278520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.